Nitric oxide triggers programmed cell death (apoptosis) of adult rat ventricular myocytes in culture

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 3 46-3, 1999, Pages

  Pinsky, David J ^a   Aji, Walif ^a   Szabolcs, Matthias ^a   Athan, Eleni S ^a   Liu, Youping ^a   Yang, Yi Ming ^a   Kline, Richard P ^a   Olson, Kim E ^a   Cannon, Paul J ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

p53; S nitroso N acetylpenicillamine

Indexed keywords

CYTOKINE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; PROTEIN P53;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONCENTRATION RESPONSE; DNA DETERMINATION; HEART MUSCLE CELL; HEART VENTRICLE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0032887709     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.3.h1189     Document Type: Article

References (69)

1. Akeson, A. L., and C. W. Woods. A fluorometric assay for the quantitation of cell adherence to endothelial cells. J. Immunol. Methods 163: 181-185, 1993.
2. Albina, J. E., S. Cui, R. B. Mateo, and J. S. Rerichner. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150: 5080-5085, 1993.
3. Ankarcrona, M., J. M. Dypbukt, B. Brune, and P. Nicotera. Interleukin-1 beta-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp. Cell Res. 213: 172-177, 1994.
4. Beauvais, F., L. Michel, and L. Dubertret. The nitric oxide donors, azide and hydroxylamine, inhibit the programmed cell death of cytokine-deprived human eosinophils. FEBS Lett. 361: 229-232, 1995.
5. Beckman, J. S., T. W. Beckman, J. Chen, P. A. Marshall, and B. A. Freeman. Apparent hydroxyl radical production by peroxy-nitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87: 1620-1624, 1994.
6. Bialik, S., D. L. Geenen, I. E. Sasson, R. Cheng, J. W. Horner, S. M. Evans, E. M. Lord, C. J. Koch, and R. N. Kitsis. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J. Clin. Invest. 100: 1363-1372, 1997.
7. Blanco, F. J., R. L. Ochs, H. Schwarz, and M. Lotz. Chondrocyte apoptosis induced by nitric oxide. Am. J. Pathol. 146: 75-85, 1995.
8. Brady, A. J. B., P. A. Poole-Wilson, S. E. Harding, and J. B. Warren. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1963-H1966, 1992.
9. Burney, S., S. Tamir, S. Gal, and S. R. Tannenbaum. A mechanistic analysis of nitric oxide-induced cellular toxicity. Nitric Oxide 1: 130-144, 1997.
10. Cheng, W., J. Kajstura, J. A. Nitahara, B. Li, K. Reiss, Y. Liu, W. A. Clark, S. Krajewski, J. C. Reed, G. Olivetti, and P. Anversa. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp. Cell Res. 226: 316-327, 1996.
11. Cheng, W., B. Li, J. Kajstura, P. Li, M. S. Wolin, E. H. Sonnenblick, T. H. Hintze, G. Olivetti, and P. Anversa. Stretch-induced programmed myocyte death. J. Clin. Invest. 96: 2247-2259, 1995.
12. Crow, J. P., and J. S. Beckman. Reactions between nitric oxide, superoxide, and peroxynitrite: footprints of peroxynitrite in vivo. Adv. Pharmacol. 34: 17-43, 1995.
13. Cui, S., J. S. Reichmer, R. B. Mateo, and J. E. Albina. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res. 54: 2462-2467, 1994.
14. DeBelder, A. J., M. W. Radomski, H. J. F. Why, P. J. Richardson, C. A. Bucknall, E. Salas, J. F. Martin, and S. Moncada. Nitric oxide synthase activities in human myocardium. Lancet 341: 84-85, 1993.
15. Dimmeler, S., M. Ankarcrona, P. Nicotera, and B. Brune. Exogenous nitric oxide (NO) generation or IL-1 beta-induced intracellular NO production stimulates inhibitory auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase in RINm5F cells. J. Immunol. 150: 2964-2971, 1993.
16. Dimmeler, S., J. Haendeler, M. Nehls, and A. M. Zeiher. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med. 185: 601-607, 1997.
17. Drapier, J. C., C. Pellat, and Y. Henry. Generation of EPR-detectable nitrosyl-iron complexes in tumor target cells cocultured with activated macrophages. J. Biol. Chem. 266: 10162-10167, 1991.
18. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. Identification of programmed cell death in situ via specific labeling of nuclear DNAfragmentation. J. Cell Biol. 119: 493-501, 1992.
19. Genaro, A. M., S. Hortelano, A. Alvarez, C. Martinez, and L. Bosca. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J. Clin. Invest. 95: 1884-1890, 1995.
20. Geng, Y., G. K. Hansson, and E. Holme. Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ. Res. 71: 1268-1276, 1992.
21. Gold, R., M. Schmied, G. Giegerich, M. Breitschopf, H. P. Hartung, K. V. Toyka, and M. Lassmann. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab. Invest. 71: 219-255, 1994.
22. Gottlieb, R. A., K. O. Burleson, R. A. Kloner, B. M. Babior, and R. L. Engler. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 94: 1621-1628, 1994.
23. Haywood, G. A., P. S. Tsao, H. E. von der Leyen, M. J. Mann, P. J. Keeling, P. T. Trindade, N. P. Lewis, C. D. Byrne, P. R. Rickenbacher, N. H. Bishopric, J. P. Cooke, W. J. McKenna, and M. B. Fowler. Expression of inducible nitric oxide synthase in human heart failure. Circulation 93: 1087-1094, 1996.
24. Ing, D. J., J. Zang, V. J. Dzau, K. A. Webster, and N. H. Bishropic. Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. Circ. Res. 84: 21-33, 1999.
25. Iwashina, M., M. Shichiri, F. Marumo, and Y. Hirata. Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells. Circulation 98: 1212-1218, 1998.
26. Jacobson, M. D., J. F. Burne, and M. C. Raff. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J. 13: 1899-1910, 1994.
27. James, T. N. Normal and abnormal consequences of apoptosis in the human heart. Circulation 90: 556-573, 1994.
28. James, T. N., E. St. Martin, P. W. Willis III, and T. O. Lohr. Apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias associated with absence of the AV node, sinus node, and internodal pathways. Circulation 93: 1424-1438, 1996.
29. Kajstura, J., W. Cheng, K. Reiss, W. A. Clark, E. H. Sonnenblick, S. Krajewski, J. C. Reed, G. Olivetti, and P. Anversa. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab. Invest. 74: 86-107, 1996.
30. Kaneto, H., J. Fujii, H. G. Seo, K. Suzuki, T. Matsuoka, M. Nakamura, H. Tatsumi, Y. Yamasaki, T. Kamada, and N. Taniguchi. Apoptotic cell death triggered by nitric oxide in pancreatic beta cells. Diabetes 44: 733-738, 1995.
31. Kerr, J. F. R., A. H. Wylie, and A. R. Currie. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer 26: 239-257, 1972.
32. Kwon, N. S., D. J. Stuehr, and C. F. Nathan. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J. Exp. Med. 174: 761-767, 1991.
33. Lancaster, J. R., Jr., and J. B. Hibbs, Jr. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc. Natl. Acad. Sci. USA 87: 1223-1227, 1990.
34. Lancaster, J. R., Jr., J. M. Langehr, H. A. Bergonia, N. Murase, R. L. Simmons, and R. A. Hoffman. EPR detection of heme and non-heme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J. Biol. Chem. 267: 10994-10998, 1992.
35. Leri, A., Y. Liu, A. Malhotra, Q. Li, P. Stiegler, P. P. Claudio, A. Giordano, J. Kajstura, T. H. Hintze, and P. Anversa. Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes. Circulation 97: 194-203, 1998.
36. Levine, A. J. p53, The cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
37. Lewis, N. P., P. S. Tsao, P. R. Rickenbacher, C. Xue, R. A. Johns, G. A. Haywood, H. von der Leyen, P. T. Trindade, J. P. Cooke, S. A. Hunt, M. E. Billingham, H. A. Valantine, and M. B. Fowler. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation 93: 720-729, 1996.
38. Liu, Y., E. Cigola, W. Cheng, J. Kajstura, G. Olivetti, T. H. Hintze, and P. Anversa. Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab. Invest. 73: 771-787, 1995.
39. MacCoubrey, I. C., P. L. Moore, and R. P. Haugland. Quantitative fluorescence measurements of cell viability (cytotoxicity) with a multi-well plate scanner. J. Cell Biol. 3: 58a, 1990.
40. Mannick, J. B., K. Asano, K. Izumi, E. Kieff, and J. S. Stamler. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79: 1137-1146, 1994.
41. Messmer, U. K., M. Ankarcrona, P. Nicotera, and B. Brune. p53 Expression in nitric oxide-induced apoptosis. FEBS Lett. 355: 23-26, 1994.
42. Messmer, U. K., E. G. Lapetina, and B. Brune. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. Mol. Pharmacol. 47: 757-765, 1995.
43. Moncada, S. The L-arginine:nitric oxide pathway. Acta Physiol. Scand. 145: 201-227, 1992.
44. Narula, J., N. Haider, R. Virmani, T. G. DiSalvo, F. D. Kolodgie, R. J. Hajjar, U. Schmidt, M. J. Semigran, G. W. Dec, and B.-A. Khaw. Apoptosis in myocytes in end-stage heart failure. N. Engl. J. Med. 335: 1182-1189, 1996.
45. Nguyen, T., D. Brunson, C. L. Crespi, B. W. Penman, J. S. Wishnok, and S. R. Tannenbaum. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA 89: 3030-3034, 1992.
46. Nishio, E., K. Fukushima, M. Shiozaki, and Y. Watanabe. Nitric oxide donor SNAP induces apoptosis in smooth muscle cells through cGMP-independent mechanism. Biochem. Biophys. Res. Commun. 221: 163-168, 1996.
47. Pinsky, D. J., B. Cai, X. Yang, C. Rodriguez, R. R. Sciacca, and P. J. Cannon. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor β. J. Clin. Invest. 95: 677-685, 1995.
48. Pinsky, D. J., S. Patton, S. Mesaros, V. Brovkovych, E. Kubaszewski, S. Grunfeld, and T. Malinski. Mechanical transduction of nitric oxide synthesis in the beating heart. Circ. Res. 81: 372-379, 1997.
49. Prives, C. How loops, B sheets, and A helices help us to understand p53. Cell 78: 543-546, 1994.
50. Sarih, M., V. Souvannavong, and A. Adam. Nitric oxide synthase induces macrophage death by apoptosis. Biochem. Biophys. Res. Commun. 191: 503-508, 1993.
51. Schwarz, M. A., J. S. Lazo, J. C. Yalowich, W. P. Allen, M. Whitmore, H. A. Bergonia, E. Tzeng, T. R. Billiar, P. D. Robbins, J. R. Lancaster, Jr., and B. R. Pitt. Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. Proc. Natl. Acad. Sci. USA 92: 4452-4456, 1995.
52. Searle, J., J. F. Kerr, and C. J. Bishop. Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol. Annu. 17: 229-259, 1982.
53. Sharov, V. G., H. N. Sabbah, H. Shimoyama, A. V. Goussev, M. Lesch, and S. Goldstein. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am. J. Pathol. 148: 141-149, 1996.
54. Shimaoka, M., T. Iida, A. Ohara, N. Taenka, T. Mashimo, T. Honda, and I. Yoshiya. NOC, a nitric-oxide-releasing compound, induces dose-dependent apoptosis in macrophages. Biochem. Biophys. Res. Commun. 209: 519-526, 1995.
55. Stamler, J. S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78: 931-936, 1994.
56. Stamler, J. S., D. I. Simon, J. A. Osborne, M. E. Mullins, O. Jaraki, and T. Michel. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. USA 89: 444-448, 1992.
57. Stuehr, D. J., and C. F. Nathan. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169: 1543-1555, 1989.
58. Sugiura, Y., and T. Matsumoto. Nucleotide-selective cleavage of duplex DNA by nitric oxide. Biochem. Biophys. Res. Commun. 211: 748-753, 1995.
59. Suzuki, H., S. M. Wildhirt, R. R. Dudek, K. S. Narayan, A. H. Bailey, and R. J. Bing. Induction of apoptosis in myocardial infarction and its possible relationship to nitric oxide synthase in macrophages. Tissue Cell 28: 89-97, 1996.
60. Szabolcs, M., R. E. Michler, X. Yang, W. Aji, D. Roy, E. Athan, R. R. Sciacca, O. P. Minanov, and P. J. Cannon. Apoptosis of cardiac myocytes during cardiac allograft rejection: relation to induction of nitric oxide synthase. Circulation 94: 1665-1673, 1996.
61. Szabolcs, M. J., S. Ravalli, O. Minanov, R. R. Sciacca, R. E. Michler, and P. J. Cannon. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation 65: 804-812, 1998.
62. Tanaka, M., H. Ito, S. Adachi, H. Akimoto, T. Nishikawa, T. Kasajima, F. Marumo, and M. Hiroe. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ. Res. 75: 426-433, 1994.
63. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
64. Tilly, J. L., and A. J. W. Hsueh. Microscale autoradiographic method for the qualitative and quantitative analysis of apoptotic DNAfragmentation. J. Cell. Physiol. 154: 519-526, 1993.
65. Welsh, N., and S. Sandler. Interleukin-1 beta induces nitric oxide production and inhibits the activity of aconitase without decreasing glucose oxidation rates in isolated pancreatic islets. Biochem. Biophys. Res. Commun. 2182: 333-340, 1992.
66. Weston, S. A., and C. R. Parish. New fluorescent dyes for lymphocyte migration studies: analysis by flow cytometry and fluorescence microscopy. J. Immunol. Methods 133: 87-97, 1990.
67. Wink, D. A., K. S. Kasprzak, C. M. Maragos, R. K. Elespuru, M. Misra, T. M. Dunams, T. A. Cebula, W. H. Koch, A. W. Andrews, J. S. Allen, and L. K. Keefer. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254: 1001-1003, 1991.
68. Worrall, N. K., W. D. Lazenby, T. P. Misko, T. S. Lin, C. P. Rodi, P. T. Manning, R. G. Tilton, J. R. Williamson, and T. B. Ferguson, Jr. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J. Exp. Med. 181: 63-70, 1995.
69. Zhang, J., V. L. Dawson, and T. M. Danson. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263: 687-689, 1994.